← FDA DRUG APPROVALS

FDA ANDA · ANDA090386

METOPROLOL TARTRATE

Sponsor: AM REGENT

APPLICATION
ANDA090386
TYPE
ANDA
ORIGINAL APPROVAL
2009-09-30
LATEST ACTION
2024-11-12
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METOPROLOL TARTRATEDiscontinued
METOPROLOL TARTRATE 1MG/ML · INJECTABLE · INJECTION

Approval history

2024-11-12Labeling · Supplement 4 · standardAP
2019-10-30Labeling · Supplement 3 · standardAP
2010-06-29Labeling · Supplement 1AP
2009-09-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →